Chrono-immunotherapy’s current and future optimization strategies: immunotherapy timing in line with the circadian rhythm brings longer survival benefits

Read full text
Authors: Daiwei Liu, Z. LI, Huijuan Cui, Haitao Zhang, Hui Li, Xiaoyuan Wu
Cited by: 4
References: 97

Abstract

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for malignant tumors such as advanced lung cancer, but their efficacy is limited. In recent years, the circadian rhythm has provided a brand-new optimization strategy for immunotherapy. This perspective article aims to explore the potential mechanisms of the interaction between immunotherapy and circadian rhythms, reviews clinical evidence supporting that "time-of-day receipt of ICIs brings better therapeutic effects", and conduct an in-depth analysis of the current practical challenges of chrono-immunotherapy. And emphasize the potential of "chrono-immunotherapy" as a valuable therapeutic approach.

Fields of Study & Subjects

Circadian rhythm and melatonin Cancer Immunotherapy and Biomarkers Dietary Effects on Health

Publication details

Journal / source
Frontiers in Immunology
Publisher
Frontiers Media SA
Volume
17
Pages
1777437–1777437
Publication date
16 February 2026
Language
EN